Loading...
Chemical structure of Navoximod

GC13519

Navoximod

Also known as 4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol

Navoximod (GDC-0919; NLG-?919) is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with Ki/EC50 of 7 nM/75 nM

ChemicalCAS1402837-78-8MW316.37FormulaC18H21FN2O2
CAS number
1402837-78-8
Molecular weight
316.37
Formula
C18H21FN2O2
Solubility
Soluble in DMSO
InChIKey
YGACXVRLDHEXKY-LHPNLFKDSA-N
Catalogue number
GC13519
Brand
GLPBIO
Computed properties PubChem CID 70914230 · XLogP 2.1 · TPSA 58.3 Ų · H-bond donors 2
XLogP
2.1
TPSA
58.3 Ų
H-bond donors
2
H-bond acceptors
4
Rotatable bonds
3
Heavy atoms
23

SMILES C1CC(CCC1[C@@H](C[C@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O

Computed descriptors from PubChem (CID 70914230), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.